The blank micelles were not toxic to V79 cells in the tested concentration ranges. Figure 9 Cytotoxicity of doxorubicin-loaded micelles on DLD-1 cells after 24 h. Twenty thousand cells were exposed to doxorubicin and doxorubicin-incorporated CA-PEI micelles for 24 h. Figure 10 Cell viability (%) of V79 cells at 24 h post-incubation with increasing concentrations of CA-PEI blank PF-3084014 mouse micelles. Conclusions Here, we report the synthesis
of doxorubicin-loaded novel CA-PEI micelles for the first time. The conjugates readily formed micelles, which exhibited a uniform spherical morphology as observed by TEM. XRD analysis revealed that the conjugates had a crystalline structure. Increasing the quantity of incorporated doxorubicin decreased the release rate of the drug. Doxorubicin-loaded CA-PEI micelles had an enhanced antitumor activity against tumor cells in vitro compared with that of doxorubicin itself. In contrast, when blank micelles were exposed to normal (V79) cells, they did not Vorinostat in vitro exhibit considerable toxicity. Together, these results indicate the potential of doxorubicin-loaded CA-PEI micelles as carriers for targeted antitumor drug delivery system. Acknowledgments This project was funded by a Research
University Grant (UKM-GUP-SK-07-23-045) from Universiti Kebangsaan Malaysia (UKM) and Science Fund (02-01-02-SF0738) from the Ministry of Science, Technology and Innovation, Malaysia. References 1. Ko J, Park K, Kim YS, Kim MS, Han JK, Kim K, Park RW, Kim IS, Song HK, Lee DS, Kwon IC: Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(signaling pathway b-amino ester) block copolymer micelles for cancer therapy. J Control Release 2007, 123:109–115.CrossRef 2. Bagul M, Kakumanu S, Wilson
T, Nicolosi R: In vitro evaluation of antiproliferative effects of self-assembling nanoemulsion of paclitaxel on various cancer cell lines. Nano Biomed Eng 2010, 2:100–108. 3. Hua MY, Yang HW, Liu HL, Tsai RY, Pang ST, Chuang KL, Chang YS, Hwang TL, Chang YH, Chuang HC, Chuang CK: Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy. Biomaterials 2011, 32:8999–9010.CrossRef 4. Bae Y, Kataoka K: Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliv Rev 2009, 61:768–784.CrossRef 5. Torchilin VP: Tumor delivery of macromolecular drugs based on the Buspirone HCl EPR effect. Adv Drug Deliv Rev 2011, 63:131–135.CrossRef 6. Gaucher G, Marchessault RH, Leroux JC: Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release 2010, 143:2–12.CrossRef 7. Yoo HS, Park TG: Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004, 96:273–283.CrossRef 8. Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W: Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release 2010, 143:136–142.CrossRef 9.